MyFinsight
Home
Blog
About
Back
Income Statement
Parabilis Medicines, Inc. (PBLS)
Parabilis Medicines, Inc. (PBLS)
source: myfinsight.com
Net loss allocable
to common...
-$66,955K
Net loss
-$52,463K
Cumulative dividends on
convertible preferred stock
$14,492K
Loss from operations
-$50,886K
Total other (expense)
income, net
-$1,577K
Collaboration revenue
$148K
Interest income
$4,189K
Total operating
expenses
$51,034K
Change in fair value of
simple agreement for...
$5,556K
Interest expense
$210K
Research and development
cost
$39,377K
General and
administrative
$11,657K
Back